Muzafarova Sh.Sh

Работ: 2

Tashkent State Medical University, Tashkent, Uzbekistan

1. FEATURES OF THE IMPACT OF NOVEL GLUCOSE-LOWERING DRUG CLASSES ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

   Muzafarova Sh.Sh, Shagazatova B.Kh

   ДругоеZenodo (CERN European Organization for Nuclear Research)2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.other.880269

2. FEATURES OF THE IMPACT OF NOVEL GLUCOSE-LOWERING DRUG CLASSES ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

   Muzafarova Sh.Sh, Shagazatova B.Kh

   ДругоеZenodo (CERN European Organization for Nuclear Research)2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.other.880295